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IndIvIdual’s HealtH – Cost studies
PIH10
usIng Hormonal ContraCePtIon reduCe unIntended PregnanCy In 
CHIna
Tang M., Mao Y., Chen Y.
Fudan University, Shanghai, China
Objectives: The potential high-unintended pregnancy rates have resulted in 
great productivity loss in China. Several contraceptive methods have been intro-
duced by both the providers and the woman themselves to reduce the unintended 
pregnancy rates.A cost-benefit analysis on various hormonal contraceptive meth-
ods was performed in order to provide references for contraception selection in 
China. MethOds: A decision-tree model was used to compare contraception costs 
and effects among different contraceptive methods. All women were classified into 
three contraception profiles (continuation, discontinuation and switch, discontinu-
ation and drop-out).Outcomes included no pregnancy, pregnancy with no birth and 
birth. All the probabilities, medical and medication data in this model were derived 
from the literature and interviews. Results: A comparison of total estimated yearly 
and cumulative costs indicated that contraceptive implants, transdermal contracep-
tive, extended-cycle OC, vaginal ring, and IUD were less costly, less than $281733.7 in 
a three-year study period. While transdermal contraceptive, extended-cycle OC and 
vaginal ring were not available in the Chinese market, contraceptive implants and 
IUD were the only two choices in China with lowest cumulative costs. The further 
cost-benefit analysis also demonstrated contraceptive implants as good value for 
money. Using contraceptive implants were proved to have the lowest cost of preg-
nancy from failure of $839.9, with a total cost of $26814.9, and a benefit-cost ratio of 
2.2, far over 1.0. Sensitivity analysis by tornado diagrams showed that cost of preg-
nancies, age and proportion of discontinuation and switch might have the greatest 
impact on the costs and failure risks of contraceptive implants. cOnclusiOns: In 
order to reduce the unintended pregnancy rates, the implementation of hormonal 
contraception may lead to a benefit in terms of both costs and effects. And among 
all the hormonal contraception in the Chinese market, contraceptive implants tend 
to generate greater economic benefits. Note:1US dollar= 6.46 Chinese yuan.
PIH11
dIsease Burden of unIntended PregnanCy In CHIna
Mao Y.1, Tang M.1, Chen Y.1, Wu S.2
1Fudan University, Shanghai, China, 2National Research Institute for Family Planning, Beijing, 
China
Objectives: China is a big country with a large population. Reproductive health 
education is not sufficient for women of childbearing age, which leads to high 
unintended pregnancy (UP) rate. These represent a significant cost to the health care 
system. This study analyzes the epidemiology and productivity loss of unintended 
pregnancy in China. MethOds: The study reviewed published scientific articles and 
policy documents related to unintended pregnancy in China. We retrieved literature 
from Wanfang and PubMed databases, and searched policy documents in websites 
of National Bureau of Statistics and National Center for Women and Children’s 
health, China CDC. Results: Almost 10% of fertile women have UP in China each 
year. There are four different results of UP, including miscarriage, elective abortion, 
ectopic pregnancy and delivery. There are two methods of elective abortion, includ-
ing operation abortion and drug abortion. The costs of operation and drug abortion 
are about US $131.58 and $100.62 in early pregnancy respectively, and $154.80 and 
$464.40 in the second trimester respectively. Drug abortion costs are much more in 
the second trimester because of complications. The incidence of ectopic pregnancy 
is about 4.4%, and there are three therapeutic methods. The costs of laparoscopic 
operation and open abdominal surgery are more than drug conservative treatment. 
The costs are between $309.60 and $1393.19. Delivery has three possibilities. Vaginal 
delivery accounted for 52.6%, and cesarean section accounted for 46.2%. The inci-
dence of premature birth is about 6.36%. Vaginal delivery and cesarean section will 
cost about $387.00 and $619.20 respectively. The costs of premature birth range from 
$928.80 to $1547.99, and the costs will be increased with high likelihood of neonatal 
weight. cOnclusiOns: UP poses a heavy economic burden in China, but the eco-
nomic burden could be reduced if fertile women receive more reproductive health 
education, get appropriate treatment and have periodical prenatal examination.
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an uPdate of Cost-effeCtIveness of rotavIrus vaCCInatIon In 
IndonesIa: takIng a BIrtH-dose vaCCInatIon strategy Into aCCount
Suwantika A.A.1, Setiawan D.2, Atthobari J.3, Postma M.J.1
1University of Groningen, Groningen, The Netherlands, 2University of Groningen, Groningen, The 
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Objectives: Rotavirus infection was reported as the major cause of severe diar-
rhea in children under 5-years-old in Indonesia. A low cost rotavirus vaccine to 
protect infants from birth has been developed for developing countries, such as 
Indonesia. This study aims to update our initial analysis on the cost-effectiveness 
of rotavirus vaccination in Indonesia, taking a birth-dose vaccination strategy 
explicitly into account. MethOds: An age-structured cohort model was developed 
for the 2013 Indonesia birth cohort. Applying different rotavirus vaccine efficacies 
for formula-fed and breastfed infants, we compared two vaccination strategies: 
(i) three-dose schedule at 2, 3 and 4 months of age, and (ii) three-dose schedule 
at 0, 1, and 2 months of age. We applied a 5-year-time-horizon with 1 monthly 
analytical cycles for children less than 1 year of age and annually thereafter. 
Also, we used Monte Carlo simulations to examine the economic acceptability 
and affordability of the rotavirus vaccination. Results: Rotavirus vaccination 
would reduce rotavirus-diarrhea cases in children under 5-years-old by 475,806 
and 489,259 cases for the first and second strategies, respectively. Considering 
amarket price of US$ 5 per dose, the Indonesian government would require budg-
ets of US$ 65.0 million and US$ 65.3 million for the first and second strategies, 
respectively.The incremental cost-effectiveness ratios wereUS$ 150 and US$ 146for 
Objectives: To assess and compare the efficacy of atropine and atropine with 
glycopyrrolate combination in organophosphate poisoning. MethOds: A retro-
spective study was conducted in a tertiary care teaching hospital of South India. 
Data was collected retrospectively from medical record section from 2012 to 2013 
in a suitable designed case record form. Data was analysed by using SPSS 20.0 with 
chi-square and one way anova. Results: Total of 199 cases of organophosphate 
poisoning was documented out of which 135(67.8%) were males and 64(32.2%) 
were females. The average age in this group of patients was found to be 34.22 + 
14.26. The average pre-hospitalization period was 1.58 + 2.07 days. Among them 
majority of the cases were suicidal (94.5%). A total of 159 patients received only 
atropine as treatment with an average hospital stay of 12.66 (SD= 11.88) days and 
a mean of 8.71(SD= 10.03) days duration in ICU. Whereas the other 40 patients 
received both atropine and glycopyrrolate as treatment with an average stay of 
15.68 (SD= 12.76) days and a mean of 12.12 (SD= 10.40) days duration in ICU. 
Amongst the 159 patients who received only atropine 40.9% received ventilation 
and for the other 40 who received atropine and gylcopyrrolate only 60% received 
ventilation. Out of the 159 patients who received only atropine 7.6% underwent 
tracheostomy and 25.8% were found to have intermediate syndrome, whereas 
for patients who received both atropine and glycopyrrolate 15.4% underwent tra-
cheostomy and 35% were found to have intermediate syndrome. cOnclusiOns: 
Efficacy of two regimens reveals that atropine was found to be more effective 
when given alone when compared with atropine and glycopyrrolate combination 
in OP poisoning.
PIH7
tHe effeCtIveness of fIrst trImester ComBIned sCreenIng on 
reduCIng tHe rate of InvasIve genetIC ProCedures In a CIty Based 
PoPulatIon of Hungary 2010-2013
Nagy S.1, Bajnoczky K.1, Boncz I.2, Kovács G.3
1Petz Aladár County Teaching Hospital, Győr, Hungary, 2University of Pécs, Pécs, Hungary, 
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Objectives: To assess the effectiveness of combined biochemical and ultrasound 
screening for chromosomal abnormalities in the first trimester of pregnancy on 
reducing the rate of invasive genetic procedures in a city based population on 
Hungary. MethOds: Previously women aged 35 years or more had access to cho-
rionic villus sampling (CVS) or amniocentesis (AC). A private prenatal diagnostic 
center offered a population based screening protocol irrespective of maternal age. 
Invasive testing was performed for women having a combined risk for fetal ane-
uploidy> 1:250. Total number of 4611 singleton and twin pregnancies in the ges-
tational age of 11+0 and 13+6 weeks were enrolled between November 2010 and 
August 2013. Maternal serum level of pregnancy associated protein-A (PAPP-A) and 
free-beta human chorionic gonadotropin (free β -hCG) were determined by KRYPTOR 
(Brahms-Thermofisher Gmbh, Germany). Results: The screening rate in this city 
based population was 60%. 277 (6,3%) women had a positive first trimester screen-
ing result. There were 16 fetuses with Down’s syndrome and 14 fetuses with other 
chormosomal abnormalities diagnosed. The sensitivity and specificity were 100% 
and 95%, the false positive rate was 4,5% and the false negative rate was 0%. The 
positive predictive value of the test was 11%, the negative predictive value was 100%. 
The number of pregnancies in which an invasive test was performed decreased 
from 518 in 2005 to 295 in 2013, or by 44%. The proportion of women aged less than 
35 years increased, while the rate of women over 35 decreased in this invasive 
group. cOnclusiOns: It is possible to change the pattern of invasive prenatal 
procedures and reduce the proportion of women having CVS or amnio. Efficient 
information is needed to increase the screening rate, especially in a self-financed 
system, where the public health insurance does not cover this type of nationwide 
screening.
PIH8
Burden of dIsease In asIan CountrIes and tHe use of dIsaBIlIty-
adjusted lIfe-years and QualIty-adjusted lIfe-years
Groom Z.C.1, Beale R.C.1, Brooks-Rooney C.2
1Costello Medical Consulting Ltd., Cambridge, UK, 2Costello Medical Singapore Pte Ltd., Singapore
Objectives: Disability-adjusted Life-years (DALYs) and Quality-adjusted Life-
years (QALYs) are two measurements commonly used in health care evaluations; 
however the specific disease areas where they are most applicable are not fully 
defined. The objective of this study was to review the use of DALYs and QALYs in 
trials taking place in China and Thailand and review the relationship with disease 
burden. MethOds: PubMed was searched for studies published after 01/01/2004 
reporting DALYs and QALYs for communicable and non-communicable diseases 
in China and Thailand. Data on disease burden were obtained from the World 
Health Organisation’s (WHO) ‘Mortality and Burden of Disease Estimates for WHO 
Member States in 2004’ database. Results: 117 studies were included for China; 
79 reported QALYs and 38 reported DALYs. 34 studies were included for Thailand 
(QALYs: 28; DALYs: 6). Of trials reporting QALYs, 74.7% of Chinese and 78.6% of 
Thai trials focussed on non-communicable disease; the most commonly investi-
gated disease was cancer. Of trials reporting DALYs, 44.7% of Chinese and 16.7% 
of Thai trials focussed on non-communicable diseases. In terms of the disease 
burden, communicable/non-communicable diseases account for 24.6%/75.4% and 
33.7%/66.3% of the burden in China and Thailand respectively. Leading causes of 
disease burden were cerebrovascular disease (7.7%) and HIV (12.0%) in China and 
Thailand respectively. cOnclusiOns: A dual burden of disease was observed in 
Asian countries in terms of non-communicable/communicable diseases. The QALY 
was the preferred measure for non-communicable diseases in China and Thailand. 
While the DALY is used equally in communicable and non-communicable diseases 
in China, it is used predominantly for non-communicable diseases in Thailand. 
This presents a challenge to health care managers; while it is clear that QALY is 
used mostly for non-communicable diseases, the most appropriate use of the 
DALY is unclear. Further research into the characteristics of diseases within these 
categories is required.
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Primary non-adherence was defined as a binary outcome representing failure to 
fill a new prescription within 30 days after the medication was prescribed to the 
patient and secondary non-adherence was defined as a number of refills obtained 
by a patient within a 12 month follow up period. Various measured patient, pre-
scription, and prescribing physician characteristics were included in the model. 
Hurdle model results indicate that important predictors are missing from the 
single-component models, but exist in the joint model of primary and secondary 
non-adherence. cOnclusiOns: The authors conclude that a hurdle modeling 
approach enables the taking of simple, well-understood models primary (logistic 
regression) and secondary non-adherence (count regression) and combine them 
in a way that provides a better description of the data than a single-component 
models provide separately.
PIH17
a QualItatIve assessment of doCtors PerCePtIon towards tHe 
QualIty of PHarmaCeutICal Care servICes In kHyBer PakHtunkHwa, 
PakIstan
Azhar S.1, Murtaza G.2, Kousar R.3
1COMSATS Institute of Information Technology, Abbottabad, Pakistan, 2COMSATS, Abbottabad 
KPK Pakistan, Pakistan, 3COMSATS, Abbottabad, Pakistan
Objectives: The main objective of this study is to explore the perception of doc-
tors regarding quality of pharmaceutical care services in Khyber Pakhtunkhwa, 
Pakistan. MethOds: A qualitative study design was adopted. A semi-structured 
interview guide was developed, through snowball sampling technique face to face 
interviews were conducted until saturation point has reached till 15th doctors. 
Doctors from public and private hospitals in Khyber Pakhtunkhwa, Pakistan who 
were interviewed from December to February 2014. The interviews were conducted 
at the doctor’s work-place. Written consent was obtained from the participants 
prior to the interview. Results: Among the respondents interviewed, nine were 
male and six female doctors. Thematic content analysis yielded 4 major themes: (a) 
Collaboration of doctors and pharmacists, (b) Lack of provision of patient counseling, 
(c) Separation of prescribing & counseling services, (d) Patient compliance through 
pharmaceutical care. cOnclusiOns: The findings demonstrated that implementa-
tion of pharmaceutical care provision would benefit the doctors and patient. Doctors 
were willing to collaborate with pharmacist because it will facilitate the doctors as 
due to time limit they are unable to do proper patient counseling. They have also 
showed positive response towards implementation of pharmacy practice which 
would definitely improve the patient compliance.
PIH18
referenCe value of Blood serum alkalIne PHosPHatase In mongolIan 
adult
Chanagsuren G.1, Dorj E.2, Dorj O.1, Gunchin B.3
1School of Nursing, HSUM, Ulaanbaatar, Mongolia, 2School of Biomedicine, HSUM, Ulaanbaatar, 
Mongolia, 3Health Sciences University of Mongolia, Ulaanbaatar, Mongolia
Objectives: To determine the reference value of blood serum alkaline phos-
phatase of adult according to related age, sex, season and region. MethOds: In 
the research, totally 3742 people were conducted. The research was implemented 
and supported by central laboratory of Biomedical school, HSUM, “Mobio” labora-
tory of Korea and “Mega” laboratory. The research of serum alkaline phosphatase 
was made by the kinetic method which is confirmed by IFCC and used the liquid 
reagent of Roche Hospitex diagnostics and Human firm. The research result was 
statistically analyzed with standard programming the SPSS statistic. Results: 
The mean value of blood serum alkaline phosphatase activity of adult with con-
fidence interval P = 0.95, the mean value was for the male 81.78±0.48, (n= 1597) 
U/L and for female 76.99±0.41 (n= 2145) U/L. While determining the Interval for 
reference value of blood serum alkaline phosphatase, interval was for male 51.08-
112.47 U/L8 U/L and for female 39.77-114.21U/L. Blood serum alkaline phosphatase 
activity of adult Mongolian have dependence of sex (p< 0.0001) and it was high 
for male. Also, serum alkaline phosphatase activity is varying (p< 0.0001, r= 0.102) 
depending on age. There is no dependence of activity of serum (p= 0.43) appeared 
by region. cOnclusiOns: Mean value of serum alkaline phosphatase activity is 
for people 70.50±0.63 U/L and minimum limit of reference value is 40.09-116.72U/L.
The activity of serum alkaline phosphatase has deference from age and sex 
with confidence interval (p= 0.0001). For male high, for female low, weak direct 
dependence from age (r= 0.102) and strong direct dependence from sex were dis-
covered.
PIH19
assessment of utIlItIes In jaPan: data avaIlaBIlIty and 
metHodology
Chen X.1, Kim H.R.2, Crawford B.1
1Adelphi Values, Tokyo, Japan, 2The University of Tokyo, Tokyo, Japan
Objectives: Utility data are essential for cost-effectiveness analyses, especially 
with the introduction of HTA in Japan in 2016. Given a paucity of information regard-
ing the availability of data and related research methodologies used in Japan, this 
study aims to present a comprehensive literature review regarding utility assess-
ment in Japan. MethOds: Medline (English) and Ichushi (Japanese) were searched 
to understand where the utilities were derived. Search terms included Utility OR 
health state preference OR 効用値 OR QALY OR 質調整生存年 [Title/Abstract] and all 
articles published before November 30, 2013 were reviewed. Articles were required 
to detail the methods for utility development or selection, and needed to be based 
in Japan. They were also required to focus on the assessment of utilities or be part 
of a cost-effectiveness analysis. Results: A total of 246 manuscripts were found 
after removing duplicates. From these, 137 were included in the full text review and 
99 were selected for analysis. The number of studies increased from 1 manuscript in 
2000 to a total of 16 in 2012 and 6 in 2013. 70 articles were cost-effectiveness analysis. 
50 articles cited utility values from previous or overseas studies. Among original util-
ity measurement studies EQ-5D and TTO were the most frequently used methods. 
the first and second strategies, respectively, which were much lower than the 2013 
Indonesian Gross Domestic Product (GDP) per capita of US$ 4,790. cOnclusiOns: 
The implementation of a birth-dose rotavirusvaccination strategy in Indonesia 
would be more cost-effective than a later vaccination schedule. The mortality 
rate and vaccine price were the most influential parameters impacting the cost-
effectiveness results.
PIH13
tHe PHarmaCoeConomICs revIew of 7-valent PneumoCoCCal 
Conjugate vaCCInatIon In asIan-PaCIfIC regIon
Zhu L.
Analysis Group, Cambridge, MA, USA
Objectives: Since 2000, when the PCV7 (7-valent Pneumococcal Conjugate Vaccine) 
gradually went public, lots of cost-effectiveness evaluations on it have been done 
in Euro-American countries. In contrast, there is little economic review on PCV7 in 
Asian-Pacific region. This review comprehensively evaluated the cost and benefit 
of introducing PCV7 into the national immunization plan (evaluation include with 
and without the herd effect) of the Asia-Pacific region, to serve as a policy reference 
for the Asian-Pacific regions in their immunization plans. MethOds: All articles 
were identified from PubMed and Embase database between January 1st, 2002 and 
June 30th, 2013 in Korea, Hong Kong, Malaysia, Singapore, Australia and Japan. The 
following keywords were used: cost, cost-effectiveness, pneumococcal diseases 
and pneumococcal conjugate vaccine. Results were collected in terms of different 
assumptions, such as incidence ratios, vaccine uptake rate, and duration of protec-
tion and so on. Costs included both direct and indirect cost. Results: The clinical 
benefits and cost effective results varied from country to country. For illnesses 
avoided, the results varied between 4,030 and 30,040 per year. In terms of deaths 
avoided, the number of events varied between 14.2 and 643 per year. Studies that 
considered herd effects reported much more favorable cost-effectiveness than those 
that did not, with the ICERs U$5,929/LYG in Hong Kong, U$10,261/LYG in Malaysia, 
U$43,275/QALY in Singapore from social perspective. cOnclusiOns: With respect 
to the WHO’s classification that an intervention is cost-effective if ICER is between 1 
And 3 times of GDP, universal PCV7 vaccination would be considered cost-effective 
in Hong Kong, Malaysia and Singapore.
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studies
PIH15
PartIal reImBursement of antIvIral agents for HBv: ImPaCt on 
antIvIral utIlIzatIon and ComPlIanCe
Qiu Q.1, Duan X.W.2, Li Y.2, Yang L.K.2, Chen Y.2, Li H.1, Duan Z.P.2, Wang L.1
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Objectives: To determine the impact of partial reimbursement on antivirals which 
was first implemented in July 1, 2011 on antiviral utilization and compliance for CHB 
patients in Beijing. MethOds: Two separate cohorts were enrolled. These consisted 
14,163 CHB outpatients who were referred to Beijing You’an Hospital during Jan 1, 
2010 to Dec 30, 2010 and 16,228 between Jul 1, 2011 and Jun 30, 2012. Follow-up ended 
on Jun 30, 2011 and Dec 31, 2012, respectively. Demographic characteristics, routine 
biochemical and virological detection results, and antiviral prescription informa-
tion were collected from electronic database. Antiviral utilization, medication pos-
session ratio (MPR) and persistence rate were compared between patients with 
medical insurance (PMI) and paid out-of-pocket (PPO). Questionnaire survey was 
given to randomly sample 307 outpatients to confirm the validity of the electronic 
database. Results: A total of 13,364 outpatients from each cohort were enrolled 
after propensity score matching. The antiviral utilization rate for PMI increased 
from 57.4 to 75.9% (P< 0.001) after the reimbursement policy and the rate among PPO 
increased from 54.9 to 56.7% (P= 0.028). A 5% increase (83.4%±24.3 vs. 88.7%±19.4%, 
P< 0.0001) in MPR was observed among PMI after reimbursement and an increase of 
under 2% was observed among PPO (83.7±24.2 vs. 85.2±23.1%, P= 0.0055). About 71% 
of the patients had more than 80% MPR in each cohort before reimbursement. This 
increased to 79.3% (P< 0.0001) and 73.0% (P= 0.0228) for PMI and PPO, respectively. PMI 
had a higher 6-, 12-, 15-month persistence rate than PPO, especially for outpatients 
receiving ETV and ADV. The questionnaire with 100% respond rate showed that more 
than 90% outpatients only took antiviral medicine at You’an Hospital, suggesting the 
validity of the electronic database. cOnclusiOns: The new reimbursement policy 
showed a positive impact on antivirals utilization as well as compliance for insured 
CHB patients, especially for patients receiving ETV and ADV.
PIH16
joInt modelIng of PrImary and seCondary non-adHerenCe outComes
Pedan A., Geng J.
InVentiv Health, Burlington, MA, USA
Objectives: Medication non-adherence to chronic therapies may severely impact 
effectiveness of treatment. Non-adherence may occur at different stages in a 
patient’s treatment journey. It may occur at the very beginning of therapy if a 
patient receives the initial prescription but does not redeem it at a pharmacy 
(primary non-adherence), or it may happen after the patient fills a prescription 
at a pharmacy but fails to follow the instructions or fails to refill the prescription 
(secondary non-adherence). MethOds: The purpose of this study is to demon-
strate that both primary and secondary non-adherences can be jointly described 
by a hurdle model, which has the interpretation as a two-part model. The first 
part is a binary outcome model, and the second part is a truncated count model 
(Poisson or negative binomial). The hurdle model is an example of the finite mix-
ture models which can be fitted by SAS’s new procedure PROC FMM. Results: 
Data in this retrospective cohort study of medication non-adherence was obtained 
from blind computerized pharmacy records of a national retail pharmacy chain. 
